Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on October 10, 2026

Oct. 10, 2026

LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress

Indeterminate GlobeNewswire

Oct. 10, 2026

vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026

Indeterminate GlobeNewswire

Oct. 10, 2026

Arla Foods Ingredients memamerkan inovasi minuman clear shake (protein bening) yang dipersonalisasi di SupplySide Global

Indeterminate GlobeNewswire

Oct. 10, 2026

Arla Foods Ingredients mempersembahkan inovasi minuman shake jernih peribadi di SupplySide Global

Indeterminate GlobeNewswire

Oct. 10, 2026

Arla Foods Ingredients จัดแสดงนวัตกรรมผลิตภัณฑ์โปรตีนใสแบบเชคสูตรเฉพาะบุคคลที่งาน SupplySide Global

Indeterminate GlobeNewswire

Oct. 10, 2026

Arla Foods Ingredients giới thiệu giải pháp thức uống protein được thiết kế riêng cho các nhu cầu khác nhau tại sự kiện SupplySide Global Arla

Indeterminate GlobeNewswire

Oct. 10, 2026

ZenaTech presenta Stacklens™, gafas de seguridad inteligentes impulsadas por IA, diseñadas para técnicos de campo y trabajadores industriales

Indeterminate GlobeNewswire

Oct. 10, 2026

ROSEN, NATIONAL TRIAL LAWYERS, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Indeterminate GlobeNewswire

Oct. 10, 2026

ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

Indeterminate GlobeNewswire

Oct. 10, 2026

Island Passage Trenching Confirms Porphyry Copper-Gold System at the EL02 Project, Bougainville Island, Papua New Guinea

Indeterminate GlobeNewswire

Oct. 10, 2026

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

Indeterminate GlobeNewswire